Latest GM & Biosafety Resources

By Gareth Jones and Mariam Mayet The focus of this paper is the emerging field of synthetic biology, in particular its implications for the African continent. Synthetic biology combines a number of scientific disciplines and is generally understood to involve the deliberate design of biological systems, using standardised components that have been created in a […]

In July 2009 The African Union Biosafety Unit communicated their concerns about the ACB’s briefing no.9, their letter can be viewed here. The original briefing can be viewed at here, The ACB’s response is titled On-going concerns about harmonisation of biosafety regulations in Africa, November 2009.

Haidee Swanby of the African Centre for Biosafety attended a meeting hosted by the African Union during May 2009 in Arusha, Tanzania on various biosafety initiatives of importance to the continent. In this briefing paper Haidee discusses the meeting and the issues and challenges lying ahead for the continent. Read here.

The Mauritian Paradox Selva Appasawmy, April 2004 OVERVIEW Mauritius has introduced legislation to regulate genetically modified organisms (GMOs) and its associated activities. This legislation perhaps represents the most stringent precautionary regulations yet on the African continent. As a Party to the Cartagena Protocol on Biosafety (Biosafety Protocol), the Mauritian government can also be said to […]

Evidently influenced by the UNEP-GEF Biosafety Project, the Biosafety Bill has been drafted principally to implement the Biosafety Protocol verbatim, and in so doing, perpetuates some of the weaknesses and deficiencies of the Biosafety Protocol. For instance, the scope of the Biosafety Bill is predicated on the scope of the Biosafety Protocol where the risks […]

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]